Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder × Myeloid × 90 days × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 140 Leukemia, Myeloid, Acute 122 Myeloproliferative Disorders 56 Leukemia, Myelomonocytic, Chronic 45 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 43 Primary Myelofibrosis 39 Precursor Cell Lymphoblastic Leukemia-Lymphoma 39 Polycythemia Vera 26 Leukemia 23 Lymphoma, Non-Hodgkin 21 Leukemia, Biphenotypic, Acute 19 Thrombocythemia, Essential 18 Hematologic Neoplasms 17 Multiple Myeloma 16 Myelodysplastic-Myeloproliferative Diseases 15 Hodgkin Disease 14 Lymphoma 13 Anemia, Refractory, with Excess of Blasts 13 Leukemia, Myeloid, Chronic-Phase 11 Hematologic Diseases 11 Leukemia, Lymphocytic, Chronic, B-Cell 10 Neoplasms 9 Recurrence 8 Histiocytosis, Langerhans-Cell 8 Blast Crisis 8 Mastocytosis 7 Lymphoproliferative Disorders 7 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 7 Bone Marrow Diseases 7 Blastic Plasmacytoid Dendritic Cell Neoplasm 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡